Free Trial

Spectral AI (MDAI) Competitors

Spectral AI logo
$2.67 +0.14 (+5.53%)
As of 01:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MDAI vs. TLSI, SGHT, BWAY, DRTS, SKIN, PROF, BSGM, INGN, ELMD, and KRMD

Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include TriSalus Life Sciences (TLSI), Sight Sciences (SGHT), Brainsway (BWAY), Alpha Tau Medical (DRTS), Beauty Health (SKIN), Profound Medical (PROF), Biosig Technologies (BSGM), Inogen (INGN), Electromed (ELMD), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry.

Spectral AI vs. Its Competitors

TriSalus Life Sciences (NASDAQ:TLSI) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 27.5% of TriSalus Life Sciences shares are held by company insiders. Comparatively, 30.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

TriSalus Life Sciences has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500.

In the previous week, Spectral AI had 5 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 5 mentions for Spectral AI and 0 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 0.62 beat Spectral AI's score of 0.37 indicating that TriSalus Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
TriSalus Life Sciences Positive
Spectral AI Neutral

TriSalus Life Sciences currently has a consensus target price of $10.75, suggesting a potential upside of 113.08%. Spectral AI has a consensus target price of $4.75, suggesting a potential upside of 76.58%. Given TriSalus Life Sciences' higher possible upside, analysts plainly believe TriSalus Life Sciences is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
Spectral AI
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Spectral AI has higher revenue and earnings than TriSalus Life Sciences. Spectral AI is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$29.43M6.49-$30.05M-$1.12-4.50
Spectral AI$29.58M2.30-$15.31M-$0.54-4.98

Spectral AI has a net margin of -30.75% compared to TriSalus Life Sciences' net margin of -84.67%.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-84.67% N/A -111.63%
Spectral AI -30.75%N/A -11.37%

Summary

Spectral AI beats TriSalus Life Sciences on 10 of the 16 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDAI vs. The Competition

MetricSpectral AIMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$68.11M$6.86B$5.50B$9.03B
Dividend YieldN/A1.16%5.39%4.11%
P/E Ratio-4.9826.5227.5220.10
Price / Sales2.30101.63397.84108.06
Price / CashN/A21.0136.1356.90
Price / Book-8.414.747.985.65
Net Income-$15.31M$173.18M$3.16B$248.47M
7 Day Performance26.29%1.57%1.91%2.80%
1 Month Performance54.60%0.21%4.17%5.62%
1 Year Performance43.85%28.65%35.76%21.20%

Spectral AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDAI
Spectral AI
2.9381 of 5 stars
$2.67
+5.5%
$4.75
+77.9%
+39.8%$67.60M$29.58M-4.9483Analyst Revision
TLSI
TriSalus Life Sciences
3.0144 of 5 stars
$5.29
-5.4%
$10.75
+103.2%
-3.2%$211.52M$29.43M-4.72106Gap Down
SGHT
Sight Sciences
0.8512 of 5 stars
$4.34
+6.9%
$4.10
-5.5%
-32.5%$209.88M$79.87M-4.43210Positive News
BWAY
Brainsway
2.2447 of 5 stars
$11.49
+5.3%
$14.25
+24.0%
+116.2%$206.14M$41.02M57.45120
DRTS
Alpha Tau Medical
2.5695 of 5 stars
$2.98
+2.8%
$8.00
+168.5%
+45.4%$204.10MN/A-6.4880
SKIN
Beauty Health
0.3197 of 5 stars
$1.93
+19.9%
$1.42
-26.6%
+7.7%$202.85M$334.30M-4.711,030Trending News
Gap Up
High Trading Volume
PROF
Profound Medical
2.5007 of 5 stars
$6.01
-5.4%
$11.50
+91.3%
-29.0%$190.84M$11.86M-4.93150
BSGM
Biosig Technologies
0.5462 of 5 stars
$7.44
+11.0%
$10.00
+34.4%
+2,656.4%$182.87M$40K0.0050High Trading Volume
INGN
Inogen
4.3148 of 5 stars
$6.67
+0.5%
$11.00
+64.9%
-3.3%$178.53M$335.70M-5.801,030Positive News
ELMD
Electromed
1.227 of 5 stars
$21.25
+3.5%
$38.00
+78.8%
+45.1%$178.20M$61.44M28.33160
KRMD
KORU Medical Systems
2.2435 of 5 stars
$3.43
+1.5%
$4.50
+31.2%
+60.4%$155.96M$33.65M-31.1880High Trading Volume

Related Companies and Tools


This page (NASDAQ:MDAI) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners